Stocks · US
TEM
XNAS
Tempus AI, Inc. Class A Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B34.09x
P/S10.59x
EPS$-1.40
ROE-57.18%
ROA-10.75%
Dividend yield0.00%
Debt/Equity3.06
Free cash flow$-263M
Returns and 52-week range
1W-12.84%
1M+11.39%
3M+25.69%
6M+53.75%
1Y-21.47%
YTD+15.43%
52W high$104.32
52W low$40.77
From 52W high-31.00%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Jazz Pharmaceuticals, Inc. | $15.3B | 16.29 | 3.19 | -6.25% |
| Solventum Corporation | $15.0B | 10.45 | 3.12 | -5.07% |
| Medpace Holdings, Inc. Common Stock | $17.3B | 35.24 | 39.92 | +1.96% |
| Charles River Laboratories International, Inc. | $14.8B | — | 5.22 | +5.71% |
| Zimmer Biomet Holdings, Inc. | $17.5B | 21.65 | 1.38 | -8.56% |
| Neurocrine Biosciences Inc | $14.7B | 20.78 | 3.97 | -6.51% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.